25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Nuformix plc
Buy, Hold or Sell?

Let's analyze Nuformix together

I guess you are interested in Nuformix plc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Nuformix plc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Nuformix plc

I send you an email if I find something interesting about Nuformix plc.

Quick analysis of Nuformix (30 sec.)










What can you expect buying and holding a share of Nuformix? (30 sec.)

How much money do you get?

How much money do you get?
p0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
p0.51
Expected worth in 1 year
p0.38
How sure are you?
45.5%

+ What do you gain per year?

Total Gains per Share
p-0.13
Return On Investment
-75.7%

For what price can you sell your share?

Current Price per Share
p0.18
Expected price per share
p0.15 - p0.22
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Nuformix (5 min.)




Live pricePrice per Share (EOD)

p0.18

Intrinsic Value Per Share

p-0.94 - p-0.08

Total Value Per Share

p-0.42 - p0.43

2. Growth of Nuformix (5 min.)




Is Nuformix growing?

Current yearPrevious yearGrowGrow %
How rich?$5.4m$6.1m-$681.3k-12.5%

How much money is Nuformix making?

Current yearPrevious yearGrowGrow %
Making money-$862.8k-$1.4m$572.7k66.4%
Net Profit Margin0.0%-2,218.0%--

How much money comes from the company's main activities?

3. Financial Health of Nuformix (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#711 / 982

Most Revenue
#808 / 982

Most Profit
#222 / 982

Most Efficient
#158 / 982
3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Nuformix? (5 min.)

Welcome investor! Nuformix's management wants to use your money to grow the business. In return you get a share of Nuformix.

What can you expect buying and holding a share of Nuformix?

First you should know what it really means to hold a share of Nuformix. And how you can make/lose money.

Speculation

The Price per Share of Nuformix is p0.175. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Nuformix.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Nuformix, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is p0.51. Based on the TTM, the Book Value Change Per Share is p-0.03 per quarter. Based on the YOY, the Book Value Change Per Share is p-0.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is p0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Nuformix.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 p% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Sharep% of Price per Share
Usd Eps0.00-0.5%0.00-0.6%0.00-1.0%0.00-0.9%0.00-0.7%
Usd Book Value Change Per Share0.000.0%0.00-0.2%0.00-0.9%0.000.0%0.000.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.00-0.2%0.00-0.9%0.000.0%0.000.3%
Usd Price Per Share0.00-0.00-0.01-0.02-0.02-
Price to Earnings Ratio-3.72--3.53--7.20--14.06--13.24-
Price-to-Total Gains Ratio-64.22--34.60--8.42--8.73--1.53-
Price to Book Ratio0.51-0.55-1.69-3.03-5.31-
Price-to-Total Gains Ratio-64.22--34.60--8.42--8.73--1.53-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.002265375
Number of shares441428
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (441428 shares)-189.33-34.65
Gains per Year (441428 shares)-757.33-138.61
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-757-7670-139-149
20-1515-15240-277-288
30-2272-22810-416-427
40-3029-30380-554-566
50-3787-37950-693-705
60-4544-45520-832-844
70-5301-53090-970-983
80-6059-60660-1109-1122
90-6816-68230-1247-1261
100-7573-75800-1386-1400

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.02.00.00.0%0.04.00.00.0%0.06.00.00.0%1.010.00.09.1%1.010.00.09.1%
Book Value Change Per Share0.02.00.00.0%1.03.00.025.0%2.04.00.033.3%5.06.00.045.5%5.06.00.045.5%
Dividend per Share0.00.02.00.0%0.00.04.00.0%0.00.06.00.0%0.00.011.00.0%0.00.011.00.0%
Total Gains per Share0.02.00.00.0%1.03.00.025.0%2.04.00.033.3%5.06.00.045.5%5.06.00.045.5%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Nuformix

About Nuformix plc

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.

Fundamental data was last updated by Penke on 2024-06-30 00:14:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Nuformix plc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Nuformix earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Nuformix to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that 0.00 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Nuformix plc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-2,218.0%+2,218.0%
TTM-5Y-545.5%+545.5%
5Y-545.5%10Y-1,408.5%+863.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--169.1%+169.1%
TTM--209.9%+209.9%
YOY-2,218.0%-234.9%-1,983.1%
5Y-545.5%-392.9%-152.6%
10Y-1,408.5%-512.4%-896.1%
1.1.2. Return on Assets

Shows how efficient Nuformix is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Nuformix to the Biotechnology industry mean.
  • -13.0% Return on Assets means that Nuformix generated -0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Nuformix plc:

  • The MRQ is -13.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -14.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.0%TTM-14.9%+2.0%
TTM-14.9%YOY-22.3%+7.4%
TTM-14.9%5Y-20.6%+5.7%
5Y-20.6%10Y-339.6%+319.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.0%-11.8%-1.2%
TTM-14.9%-11.9%-3.0%
YOY-22.3%-11.2%-11.1%
5Y-20.6%-13.3%-7.3%
10Y-339.6%-14.7%-324.9%
1.1.3. Return on Equity

Shows how efficient Nuformix is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Nuformix to the Biotechnology industry mean.
  • -13.7% Return on Equity means Nuformix generated -0.14 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Nuformix plc:

  • The MRQ is -13.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -15.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.7%TTM-15.8%+2.2%
TTM-15.8%YOY-23.4%+7.6%
TTM-15.8%5Y-22.8%+6.9%
5Y-22.8%10Y4.8%-27.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.7%-14.1%+0.4%
TTM-15.8%-15.2%-0.6%
YOY-23.4%-14.0%-9.4%
5Y-22.8%-18.8%-4.0%
10Y4.8%-19.4%+24.2%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Nuformix plc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Nuformix is operating .

  • Measures how much profit Nuformix makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Nuformix to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated 0.00  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Nuformix plc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-2,540.5%+2,540.5%
TTM-5Y-614.7%+614.7%
5Y-614.7%10Y-1,298.9%+684.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--346.7%+346.7%
TTM--218.9%+218.9%
YOY-2,540.5%-238.4%-2,302.1%
5Y-614.7%-400.7%-214.0%
10Y-1,298.9%-514.0%-784.9%
1.2.2. Operating Ratio

Measures how efficient Nuformix is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are 0.00 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Nuformix plc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY26.405-26.405
TTM-5Y6.812-6.812
5Y6.81210Y13.808-6.996
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.003-3.003
TTM-3.247-3.247
YOY26.4053.454+22.951
5Y6.8125.124+1.688
10Y13.8086.570+7.238
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Nuformix plc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Nuformix is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.51 means the company has 1.51 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Nuformix plc:

  • The MRQ is 1.510. The company is able to pay all its short-term debts. +1
  • The TTM is 1.464. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.510TTM1.464+0.046
TTM1.464YOY3.468-2.004
TTM1.4645Y2.455-0.991
5Y2.45510Y2.816-0.361
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5103.793-2.283
TTM1.4644.066-2.602
YOY3.4684.958-1.490
5Y2.4555.996-3.541
10Y2.8166.335-3.519
1.3.2. Quick Ratio

Measures if Nuformix is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Nuformix to the Biotechnology industry mean.
  • A Quick Ratio of 1.43 means the company can pay off 1.43 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Nuformix plc:

  • The MRQ is 1.430. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.424. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.430TTM1.424+0.006
TTM1.424YOY3.351-1.927
TTM1.4245Y2.390-0.966
5Y2.39010Y18.822-16.432
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4303.192-1.762
TTM1.4243.581-2.157
YOY3.3514.835-1.484
5Y2.3905.948-3.558
10Y18.8226.457+12.365
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Nuformix plc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Nuformix assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Nuformix to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.05 means that Nuformix assets are financed with 5.0% credit (debt) and the remaining percentage (100% - 5.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Nuformix plc:

  • The MRQ is 0.050. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.056. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.050TTM0.056-0.005
TTM0.056YOY0.048+0.008
TTM0.0565Y0.077-0.022
5Y0.07710Y1.158-1.080
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0500.328-0.278
TTM0.0560.339-0.283
YOY0.0480.286-0.238
5Y0.0770.367-0.290
10Y1.1580.383+0.775
1.4.2. Debt to Equity Ratio

Measures if Nuformix is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Nuformix to the Biotechnology industry mean.
  • A Debt to Equity ratio of 5.3% means that company has 0.05 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Nuformix plc:

  • The MRQ is 0.053. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.059. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.053TTM0.059-0.006
TTM0.059YOY0.050+0.009
TTM0.0595Y0.087-0.028
5Y0.08710Y0.346-0.259
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0530.363-0.310
TTM0.0590.412-0.353
YOY0.0500.367-0.317
5Y0.0870.438-0.351
10Y0.3460.476-0.130
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Nuformix plc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every 1 in earnings Nuformix generates.

  • Above 15 is considered overpriced but always compare Nuformix to the Biotechnology industry mean.
  • A PE ratio of -3.72 means the investor is paying -3.72 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Nuformix plc:

  • The EOD is -2.502. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.718. Based on the earnings, the company is expensive. -2
  • The TTM is -3.530. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.502MRQ-3.718+1.215
MRQ-3.718TTM-3.530-0.188
TTM-3.530YOY-7.203+3.674
TTM-3.5305Y-14.063+10.534
5Y-14.06310Y-13.243-0.820
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.502-2.652+0.150
MRQ-3.718-3.015-0.703
TTM-3.530-2.881-0.649
YOY-7.203-3.574-3.629
5Y-14.063-6.225-7.838
10Y-13.243-6.348-6.895
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Nuformix plc:

  • The EOD is -2.625. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.900. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.882. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.625MRQ-3.900+1.275
MRQ-3.900TTM-4.882+0.982
TTM-4.882YOY-5.936+1.054
TTM-4.8825Y-23.561+18.679
5Y-23.56110Y-18.522-5.039
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.625-3.251+0.626
MRQ-3.900-3.787-0.113
TTM-4.882-3.794-1.088
YOY-5.936-5.044-0.892
5Y-23.561-8.020-15.541
10Y-18.522-8.669-9.853
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Nuformix is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.51 means the investor is paying 0.51 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Nuformix plc:

  • The EOD is 0.342. Based on the equity, the company is cheap. +2
  • The MRQ is 0.508. Based on the equity, the company is cheap. +2
  • The TTM is 0.554. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.342MRQ0.508-0.166
MRQ0.508TTM0.554-0.046
TTM0.554YOY1.686-1.132
TTM0.5545Y3.035-2.480
5Y3.03510Y5.315-2.280
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.3421.991-1.649
MRQ0.5082.271-1.763
TTM0.5542.296-1.742
YOY1.6862.385-0.699
5Y3.0353.670-0.635
10Y5.3154.162+1.153
2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Nuformix plc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.004-0.033+718%-0.116+2759%-0.006+50%0.047-109%
Book Value Per Share--0.5120.5140%0.578-11%0.557-8%0.358+43%
Current Ratio--1.5101.464+3%3.468-56%2.455-38%2.816-46%
Debt To Asset Ratio--0.0500.056-9%0.048+6%0.077-35%1.158-96%
Debt To Equity Ratio--0.0530.059-10%0.050+6%0.087-39%0.346-85%
Dividend Per Share----0%-0%-0%-0%
Eps---0.070-0.081+16%-0.135+94%-0.124+78%-0.095+36%
Free Cash Flow Per Share---0.067-0.060-10%-0.164+146%-0.087+30%-0.076+14%
Free Cash Flow To Equity Per Share---0.032-0.028-11%-0.147+361%-0.008-75%-0.002-94%
Gross Profit Margin--1.6881.344+26%1.638+3%1.498+13%1.271+33%
Intrinsic Value_10Y_max---0.083--------
Intrinsic Value_10Y_min---0.937--------
Intrinsic Value_1Y_max---0.061--------
Intrinsic Value_1Y_min---0.097--------
Intrinsic Value_3Y_max---0.144--------
Intrinsic Value_3Y_min---0.291--------
Intrinsic Value_5Y_max---0.178--------
Intrinsic Value_5Y_min---0.482--------
Market Cap143379073.600-49%213020337.920233503062.720-9%798826267.200-73%1398970103.840-85%1075901671.767-80%
Net Profit Margin----0%-22.1800%-5.4550%-14.0850%
Operating Margin----0%-25.4050%-6.1470%-12.9890%
Operating Ratio----0%26.405-100%6.812-100%13.808-100%
Pb Ratio0.342-49%0.5080.554-8%1.686-70%3.035-83%5.315-90%
Pe Ratio-2.502+33%-3.718-3.530-5%-7.203+94%-14.063+278%-13.243+256%
Price Per Share0.175-49%0.2600.285-9%0.975-73%1.708-85%1.313-80%
Price To Free Cash Flow Ratio-2.625+33%-3.900-4.882+25%-5.936+52%-23.561+504%-18.522+375%
Price To Total Gains Ratio-43.226+33%-64.221-34.602-46%-8.424-87%-8.727-86%-1.532-98%
Quick Ratio--1.4301.424+0%3.351-57%2.390-40%18.822-92%
Return On Assets---0.130-0.149+15%-0.223+72%-0.206+59%-3.396+2519%
Return On Equity---0.137-0.158+16%-0.234+71%-0.228+67%0.048-387%
Total Gains Per Share---0.004-0.033+718%-0.116+2759%-0.006+50%0.047-109%
Usd Book Value--5430471.5135451940.7960%6133291.809-11%5912695.848-8%3791865.540+43%
Usd Book Value Change Per Share--0.0000.000+718%-0.001+2759%0.000+50%0.001-109%
Usd Book Value Per Share--0.0070.0070%0.007-11%0.007-8%0.005+43%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.001-0.001+16%-0.002+94%-0.002+78%-0.001+36%
Usd Free Cash Flow---707097.324-633870.695-10%-1741965.932+146%-921551.961+30%-805394.145+14%
Usd Free Cash Flow Per Share---0.001-0.001-10%-0.002+146%-0.001+30%-0.001+14%
Usd Free Cash Flow To Equity Per Share--0.0000.000-11%-0.002+361%0.000-75%0.000-94%
Usd Market Cap1856042.108-49%2757548.2743022697.147-9%10340806.029-73%18109667.994-85%13927547.141-80%
Usd Price Per Share0.002-49%0.0030.004-9%0.013-73%0.022-85%0.017-80%
Usd Profit---741722.610-862859.331+16%-1435591.439+94%-1318924.842+78%-1057591.627+43%
Usd Revenue----0%64725.000-100%300011.163-100%165449.793-100%
Usd Total Gains Per Share--0.0000.000+718%-0.001+2759%0.000+50%0.001-109%
 EOD+3 -5MRQTTM+17 -13YOY+18 -145Y+18 -1410Y+16 -16

3.2. Fundamental Score

Let's check the fundamental score of Nuformix plc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.502
Price to Book Ratio (EOD)Between0-10.342
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.430
Current Ratio (MRQ)Greater than11.510
Debt to Asset Ratio (MRQ)Less than10.050
Debt to Equity Ratio (MRQ)Less than10.053
Return on Equity (MRQ)Greater than0.15-0.137
Return on Assets (MRQ)Greater than0.05-0.130
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Nuformix plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.963
Ma 20Greater thanMa 500.174
Ma 50Greater thanMa 1000.185
Ma 100Greater thanMa 2000.194
OpenGreater thanClose0.183
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in GBP. All numbers in thousands.

Summary
Total Assets4,418
Total Liabilities223
Total Stockholder Equity4,195
 As reported
Total Liabilities 223
Total Stockholder Equity+ 4,195
Total Assets = 4,418

Assets

Total Assets4,418
Total Current Assets337
Long-term Assets4,081
Total Current Assets
Cash And Cash Equivalents 203
Net Receivables 116
Other Current Assets 18
Total Current Assets  (as reported)337
Total Current Assets  (calculated)337
+/-0
Long-term Assets
Goodwill 4,023
Intangible Assets 4,081
Long-term Assets Other -4,023
Long-term Assets  (as reported)4,081
Long-term Assets  (calculated)4,081
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities223
Long-term Liabilities0
Total Stockholder Equity4,195
Total Current Liabilities
Accounts payable 70
Other Current Liabilities 153
Total Current Liabilities  (as reported)223
Total Current Liabilities  (calculated)223
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock744
Retained Earnings -5,265
Accumulated Other Comprehensive Income 2,059
Other Stockholders Equity 6,657
Total Stockholder Equity (as reported)4,195
Total Stockholder Equity (calculated)4,195
+/-0
Other
Cash and Short Term Investments 203
Common Stock Shares Outstanding 719,462
Liabilities and Stockholders Equity 4,418
Net Debt -203
Net Working Capital 114



Balance Sheet

Currency in GBP. All numbers in thousands.

 Trend2023-09-302023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-12-312015-07-312014-07-31
> Total Assets 
1
0
725
545
20
5,027
4,635
5,126
6,011
4,976
4,502
4,418
4,4184,5024,9766,0115,1264,6355,0272054572501
   > Total Current Assets 
0
0
725
545
20
714
347
796
1,823
825
388
337
3373888251,8237963477142054572500
       Cash And Cash Equivalents 
0
0
685
502
6
338
4
544
1,670
464
259
203
2032594641,6705444338650268500
       Net Receivables 
0
69
0
43
83
350
328
207
139
333
129
116
11612933313920732835083430690
       Other Current Assets 
0
0
0
43
14
26
15
45
15
28
0
18
18028154515261443000
   > Long-term Assets 
0
0
0
0
236
4,313
4,288
4,331
4,188
4,151
4,114
4,081
4,0814,1144,1514,1884,3314,2884,3132360000
       Property Plant Equipment 
0
0
0
3
2
37
28
83
1
0
2
0
020183283723000
       Goodwill 
0
0
0
0
0
4,023
4,023
4,023
4,023
4,023
4,023
4,023
4,0234,0234,0234,0234,0234,0234,02300000
       Intangible Assets 
0
0
0
175
234
252
237
4,248
4,187
4,150
90
4,081
4,081904,1504,1874,248237252234175000
> Total Liabilities 
0
0
70
42
199
534
820
384
325
238
274
223
223274238325384820534199427000
   > Total Current Liabilities 
0
0
70
42
199
534
820
347
325
238
274
223
223274238325347820534199427000
       Short-term Debt 
0
0
0
0
188
23
15
38
0
0
0
0
00003815231880000
       Short Long Term Debt 
0
0
0
0
0
23
15
12
0
0
0
0
000012152300000
       Accounts payable 
0
0
0
36
163
90
322
131
99
12
274
70
7027412991313229016336000
       Other Current Liabilities 
0
0
0
6
-152
421
482
178
226
226
0
153
1530226226178482421-1526000
   > Long-term Liabilities 
0
0
0
36
163
0
337
37
99
12
274
0
0274129937337016336000
> Total Stockholder Equity
0
0
0
502
-180
4,493
3,815
4,743
5,686
4,738
4,228
4,195
4,1954,2284,7385,6864,7433,8154,493-180502000
   Common Stock
0
0
0
96
96
461
461
490
592
616
709
744
7447096165924904614619696000
   Retained Earnings -5,265-8,110-4,405-3,296-2,043-4,231-2,570-1,035-350-198-10
   Capital Surplus 000000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
1
1
0
737
737
5,877
5,877
4,480
6,385
6,501
11,629
6,657
6,65711,6296,5016,3854,4805,8775,877737737011



Balance Sheet

Currency in GBP. All numbers in thousands.




Cash Flow

Currency in GBP. All numbers in thousands.




Income Statement

Currency in GBP. All numbers in thousands.


Latest Income Statement (annual, 2023-09-30)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-37
Gross Profit-37-37
 
Operating Income (+$)
Gross Profit-37
Operating Expense-558
Operating Income-595-595
 
Operating Expense (+$)
Research Development163
Selling General Administrative619
Selling And Marketing Expenses394
Operating Expense5581,176
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-595
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-619-571
EBIT - interestExpense = -595
-619
-573
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-595-619
Earnings Before Interest and Taxes (EBITDA)-558
 
After tax Income (+$)
Income Before Tax-619
Tax Provision-0
Net Income From Continuing Ops0-619
Net Income-573
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses595
Total Other Income/Expenses Net-240
 

Technical Analysis of Nuformix
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Nuformix. The general trend of Nuformix is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Nuformix's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Nuformix plc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.2 < 0.22 < 0.22.

The bearish price targets are: 0.15 > 0.15 > 0.15.

Tweet this
Nuformix plc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Nuformix plc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Nuformix plc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Nuformix plc. The current macd is -0.00318101.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Nuformix price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Nuformix. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Nuformix price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Nuformix plc Daily Moving Average Convergence/Divergence (MACD) ChartNuformix plc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Nuformix plc. The current adx is 21.54.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Nuformix shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Nuformix plc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Nuformix plc. The current sar is 0.2.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Nuformix plc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Nuformix plc. The current rsi is 43.96. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Nuformix plc Daily Relative Strength Index (RSI) ChartNuformix plc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Nuformix plc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -3/(-6 +6).

  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Nuformix price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Nuformix plc Daily Stochastic Oscillator ChartNuformix plc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Nuformix plc. The current cci is -49.13710838.

Nuformix plc Daily Commodity Channel Index (CCI) ChartNuformix plc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Nuformix plc. The current cmo is -13.17846048.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Nuformix plc Daily Chande Momentum Oscillator (CMO) ChartNuformix plc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Nuformix plc. The current willr is -50.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Nuformix is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Nuformix plc Daily Williams %R ChartNuformix plc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Nuformix plc.

Nuformix plc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Nuformix plc. The current atr is 0.02878555.

Nuformix plc Daily Average True Range (ATR) ChartNuformix plc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Nuformix plc. The current obv is -22,712,145.

Nuformix plc Daily On-Balance Volume (OBV) ChartNuformix plc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Nuformix plc. The current mfi is 41.45.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Nuformix plc Daily Money Flow Index (MFI) ChartNuformix plc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Nuformix plc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-05-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-05-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-05-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-05-31BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-06-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-06-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside

6.3. Candlestick Patterns

Nuformix plc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Nuformix plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.963
Ma 20Greater thanMa 500.174
Ma 50Greater thanMa 1000.185
Ma 100Greater thanMa 2000.194
OpenGreater thanClose0.183
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Nuformix with someone you think should read this too:
  • Are you bullish or bearish on Nuformix? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Nuformix? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Nuformix plc

I send you an email if I find something interesting about Nuformix plc.


Comments

How you think about this?

Leave a comment

Stay informed about Nuformix plc.

Receive notifications about Nuformix plc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.